Maine voters approve Medicaid expansion; Ohio drug pricing measure rejected

AHA News Now

Voters in Maine yesterday approved a ballot measure that would allow at least 80,000 low-income Maine residents to qualify for Medicaid under the Affordable Care Act. Maine will be the 33rd state (including D.C.) to expand the program under the ACA. It also is the first state in which voters, not... read more

Topic: Advocacy and Public Policy
Tags: Medicaid, drug prices

Hearing highlights benefits of 340B Drug Pricing Program

AHA News Now

The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care organizations at... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicare, Medicaid, drug prices

Majority of House members urge CMS to abandon proposal to cut 340B program

AHA News Now

Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “Given the important role that the 340B program plays in our... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

HRSA delays to July effective date of 340B drug ceiling price rule

AHA News Now

The Health Resources and Services Administration today delayed to July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. “We are delaying the effective date of the Jan. 5, 2017, final rule to July 1, 2018, because the delay will... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

AHA opposes any further delay of 340B drug ceiling price rule

AHA News Now

The AHA today urged the Health Resources and Services Administration to implement its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers without delay. “Delaying the implementation of the ceiling price and CMPs an additional nine months – from Oct. 1, 2017 to July 1,... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, drug prices

Senate holds hearing on health care cost, coverage issues

AHA News Now

The Senate Finance Committee today held a hearing on issues impacting health care costs and coverage. Witnesses included former Centers for Medicare & Medicaid Services Acting Administrator Andy Slavitt and representatives from the Foundation for Research on Equal Opportunity, Heritage Foundation, and... read more

Topic: Advocacy and Public Policy
Tags: Coverage, drug prices

AHA urges CMS to withdraw proposed cut to 340B program

AHA News Now

The Centers for Medicare & Medicaid Services should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA today told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018. “CMS lacks... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare, rural, Critical Access Hospitals, regulation, drug prices

President signs FDA Reauthorization Act

AHA News Now

President Trump Friday signed into law the FDA Reauthorization Act (H.R. 2430). The bill reauthorizes and amends four FDA user fee programs under which companies that develop drugs and medical devices partially pay for premarket review of their products. The bill also includes provisions intended to... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Senate passes FDA Reauthorization Act

AHA News Now

The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R. 2430), sending the legislation to the president for his signature. The bill reauthorizes and amends four FDA user fee programs under which companies that develop drugs and medical devices partially pay for premarket review of... read more

Topic: Advocacy and Public Policy
Tags: regulation, opioids, drug prices

Democratic leaders unveil economic agenda

AHA News Now

Senate Democratic Leader Charles Schumer and House Democratic Leader Nancy Pelosi today unveiled an economic plan focused on improving wages, lowering costs and boosting job opportunities. To lower the cost of prescription drugs, the plan calls for creating a new agency to investigate and take action... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

Keyword Search

Date